LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | XMD16-144 | 1.11 | uM | LJP5 | 1 | M09 | 72 | hr | 658 | 697 | 3908 | 0.1783 | 0.0225 |
Hs 578T | XMD16-144 | 1.11 | uM | LJP5 | 2 | M09 | 72 | hr | 658 | 684 | 3953 | 0.1730 | 0.0150 |
Hs 578T | XMD16-144 | 1.11 | uM | LJP5 | 3 | M09 | 72 | hr | 658 | 735 | 3938 | 0.1866 | 0.0437 |
Hs 578T | XMD16-144 | 3.33 | uM | LJP5 | 1 | M08 | 72 | hr | 658 | 652 | 3908 | 0.1668 | -0.0037 |
Hs 578T | XMD16-144 | 3.33 | uM | LJP5 | 2 | M08 | 72 | hr | 658 | 562 | 3953 | 0.1421 | -0.0593 |
Hs 578T | XMD16-144 | 3.33 | uM | LJP5 | 3 | M08 | 72 | hr | 658 | 602 | 3938 | 0.1529 | -0.0340 |
Hs 578T | XMD16-144 | 10 | uM | LJP5 | 1 | M07 | 72 | hr | 658 | 493 | 3908 | 0.1261 | -0.1064 |
Hs 578T | XMD16-144 | 10 | uM | LJP5 | 2 | M07 | 72 | hr | 658 | 502 | 3953 | 0.1270 | -0.0994 |
Hs 578T | XMD16-144 | 10 | uM | LJP5 | 3 | M07 | 72 | hr | 658 | 457 | 3938 | 0.1160 | -0.1318 |
Hs 578T | Erlotinib | 0.04 | uM | LJP5 | 1 | M24 | 72 | hr | 658 | 3571 | 3908 | 0.9137 | 0.9309 |
Hs 578T | Erlotinib | 0.04 | uM | LJP5 | 2 | M24 | 72 | hr | 658 | 3824 | 3953 | 0.9672 | 0.9744 |
Hs 578T | Erlotinib | 0.04 | uM | LJP5 | 3 | M24 | 72 | hr | 658 | 3830 | 3938 | 0.9725 | 0.9785 |
Hs 578T | Erlotinib | 0.12 | uM | LJP5 | 1 | M23 | 72 | hr | 658 | 3815 | 3908 | 0.9761 | 0.9813 |
Hs 578T | Erlotinib | 0.12 | uM | LJP5 | 2 | M23 | 72 | hr | 658 | 3632 | 3953 | 0.9186 | 0.9354 |
Hs 578T | Erlotinib | 0.12 | uM | LJP5 | 3 | M23 | 72 | hr | 658 | 3805 | 3938 | 0.9661 | 0.9735 |
Hs 578T | Erlotinib | 0.37 | uM | LJP5 | 1 | M22 | 72 | hr | 658 | 3641 | 3908 | 0.9316 | 0.9456 |
Hs 578T | Erlotinib | 0.37 | uM | LJP5 | 2 | M22 | 72 | hr | 658 | 3763 | 3953 | 0.9518 | 0.9621 |
Hs 578T | Erlotinib | 0.37 | uM | LJP5 | 3 | M22 | 72 | hr | 658 | 3864 | 3938 | 0.9811 | 0.9853 |
Hs 578T | Erlotinib | 1.11 | uM | LJP5 | 1 | M21 | 72 | hr | 658 | 3748 | 3908 | 0.9589 | 0.9676 |
Hs 578T | Erlotinib | 1.11 | uM | LJP5 | 2 | M21 | 72 | hr | 658 | 3799 | 3953 | 0.9609 | 0.9694 |
Hs 578T | Erlotinib | 1.11 | uM | LJP5 | 3 | M21 | 72 | hr | 658 | 3755 | 3938 | 0.9534 | 0.9634 |
Hs 578T | Erlotinib | 3.33 | uM | LJP5 | 1 | M20 | 72 | hr | 658 | 3567 | 3908 | 0.9126 | 0.9301 |
Hs 578T | Erlotinib | 3.33 | uM | LJP5 | 2 | M20 | 72 | hr | 658 | 3691 | 3953 | 0.9336 | 0.9475 |
Hs 578T | Erlotinib | 3.33 | uM | LJP5 | 3 | M20 | 72 | hr | 658 | 3590 | 3938 | 0.9115 | 0.9295 |
Hs 578T | Erlotinib | 10 | uM | LJP5 | 1 | M19 | 72 | hr | 658 | 2384 | 3908 | 0.6100 | 0.6500 |